Correlation Between Visa and Faron Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Visa and Faron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Faron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Faron Pharmaceuticals Oy, you can compare the effects of market volatilities on Visa and Faron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Faron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Faron Pharmaceuticals.

Diversification Opportunities for Visa and Faron Pharmaceuticals

-0.7

Correlation Coefficient

Visa  Faron Pharmaceuticals

Excellent diversification

The 3 months correlation between Visa and Faron is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Faron Pharmaceuticals Oy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Faron Pharmaceuticals and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Faron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Faron Pharmaceuticals has no effect on the direction of Visa i.e., Visa and Faron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Visa and Faron Pharmaceuticals

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.34 times more return on investment than Faron Pharmaceuticals. However, Visa Class A is 2.97 times less risky than Faron Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Faron Pharmaceuticals Oy is currently generating about -0.09 per unit of risk. If you would invest  28,422  in Visa Class A on September 20, 2024 and sell it today you would earn a total of  3,066  from holding Visa Class A or generate 10.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.46%
Values	Daily Returns

Visa Class A  vs.  Faron Pharmaceuticals Oy

Visa Class A

Risk-Adjusted Performance

10 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Faron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Visa and Faron Pharmaceuticals

The main advantage of trading using opposite Visa and Faron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Faron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Faron Pharmaceuticals will offset losses from the drop in Faron Pharmaceuticals' long position.

The idea behind Visa Class A and Faron Pharmaceuticals Oy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.